Clinical trial

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer

NCT00078910

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-08-01

PhasePHASE2

Study timeline

Study start (unknown)2003-08-01Date precision: month

Registry last updated2013-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

exisulindDRUG

conventional surgeryPROCEDURE

neoadjuvant therapyPROCEDURE

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

JacksonvilleFlorida, United States1 RochesterMinnesota, United States1 ScottsdaleArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00078910 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.